Laboratory for Experimental Oncology & Radiobiology, Centre for Experimental Molecular Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
EMBO Rep. 2013 Aug;14(8):686-95. doi: 10.1038/embor.2013.92. Epub 2013 Jul 12.
Cancers of various organs have been categorized into distinct subtypes after increasingly sophisticated taxonomies. Additionally, within a seemingly homogeneous subclass, individual cancers contain diverse tumour cell populations that vary in important cancer-specific traits such as clonogenicity and invasive potential. Differences that exist between and within a given tumour type have hampered significantly both the proper selection of patients that might benefit from therapy, as well as the development of new targeted agents. In this review, we discuss the differences associated with organ-specific cancer subtypes and the factors that contribute to intra-tumour heterogeneity. It is of utmost importance to understand the biological causes that distinguish tumours as well as distinct tumour cell populations within malignancies, as these will ultimately point the way to more rational anti-cancer treatments.
在日益复杂的分类方法之后,各种器官的癌症已经被分为不同的亚型。此外,在看似同质的子类中,单个癌症包含不同的肿瘤细胞群体,这些群体在克隆形成能力和侵袭潜力等重要的癌症特异性特征上存在差异。给定肿瘤类型之间和内部存在的差异,极大地阻碍了对可能受益于治疗的患者的正确选择,以及新的靶向药物的开发。在这篇综述中,我们讨论了与特定器官癌症亚型相关的差异以及导致肿瘤内异质性的因素。了解区分肿瘤以及恶性肿瘤内不同肿瘤细胞群体的生物学原因至关重要,因为这些原因最终将为更合理的抗癌治疗指明方向。